Free Shipping Orders >$250
✓ FREE & Private Global Delivery ›
✓ We Dispatch The Freshest Batch
✓ Discreet Shipping Within 24h Daily
✓ 100% Original Products Guaranteed
✓ Great Customer Service
✓ Competitive prices on all products
✓ Only Secure Card Payment Methods ›
✓ Our genuinely Earned Reputation ›
✓ Buy more - Save more ›

Victoza® Liraglutide Pre-Filled Pen

Liraglutide 6mg/ml Solution for Injection

(1 customer review)

USD $231.00

Victoza® Pre-Filled Pen Liraglutide 6mg/ml Solution for Injection is a diabetes medication you inject once a day to lower your blood sugar and lower your risk of heart disease.

Victoza® Pre-Filled Pen Liraglutide 6mg/ml Solution for Injection is a glucagon-like peptide-1 (GLP-1) receptor agonist. By activating the GLP-1 receptor this medication tells your body to release more insulin, stops the body from releasing more sugar, and slows down digestion.

What is Victoza (liraglutide) used for?

  • Type 2 diabetes (age 10 and older)
  • Reduce the risk of major adverse heart events (like a heart attack) in adults with type 2 diabetes and established heart disease
  • Weight loss
Size: 3ml in 1 Pre-Filled Pen
Brand name: Saxenda
Title Range Discount
Items: 2 - 4 5%
Items: 5 - 8 10%
Items: 9 + 15%


What is Victoza® Liraglutide 6mg/ml Pre-Filled Pen?

Victoza Solution for Injection is an anti-diabetic medication. It works by increasing the release of insulin from the pancreas, decreasing hormones that raise blood sugar levels, slow down digestion, and reduce appetite.

  1. For adults and children 10 years of age and older with type 2 diabetes: Victoza® is a once-daily noninsulin medicine that lowers blood sugar and A1C.
  2. For adults with type 2 diabetes with known heart disease: Victoza® reduces the risk of major cardiovascular events such as heart attack, stroke, or death.

Liraglutide, which was originally approved as the antidiabetic drug Victoza, has now also been approved for use as adjunctive therapy for weight loss under the trade name Saxenda. The daily dosage is larger when it’s used for weight loss than when it’s used to control type 2 diabetes. Liraglutide may increase the risk of medullary thyroid carcinoma. Liraglutide weight loss treatment injections are available online at okdermo store. You can always buy saxenda online at okdermo as well.

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist marketed as an antidiabetic drug under the trade name Victoza. The same drug has now been approved under a new brand name, Saxenda, as an adjunct treatment for obesity. It is to be used in combination with a low-calorie diet and increased physical activity in adults with a body mass index (BMI) of 30 or higher (indicating obesity). It can also be used when the BMI is between 27 and 29 (indicating overweight) if the patient also has at least one weight-related condition, such as hypertension, type 2 diabetes, or dyslipidemia.

Victoza® Pre-Filled Pen is a medicine used to lower blood sugar levels in adults with type 2 diabetes mellitus. This helps to prevent serious complications of diabetes like kidney damage and blindness. Proper control of diabetes also helps to lower your chances of a heart attack or a stroke.

Victoza® Pre-Filled Pen belongs to the GLP-1 (glucagon-like peptide) group of diabetes medicines. It works by helping your body produce insulin and by reducing appetite. It also helps to reduce weight in some people. This medicine should be stored in a refrigerator until you need it but do not freeze it.

It is normally injected under the skin once daily. The dose will depend on your condition and what other diabetes medicines you are taking. You can use it at any time of the day with or without food but try to use it at the same time each day to get the most benefit. Your doctor or nurse will show you how and where to inject the medicine. Follow the instructions carefully.

Do not stop taking this medicine without talking to your doctor. If you do, your blood sugar levels may increase and put you at risk of serious complications. Remember that it is only part of a treatment program that should also include a healthy diet and regular exercise as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.

The most common side effects of this medicine include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation. It can also lead to low blood sugar levels (hypoglycemia) especially if you are also taking other medicines like insulin or sulphonylureas for treatment of diabetes. To prevent this, it is important to have regular meals and always carry a fast-acting source of glucose such as sugary candy or glucose candy with you.

Before using it, let your doctor know if you have any pancreas or stomach problems or severe dehydration (loss of body water), or diabetic ketoacidosis (a complication of diabetes characterized by too much acid and ketones in your blood). This medicine may not be suitable. Pregnant or breastfeeding women should also consult their doctor before using this medicine. If you experience blurred vision, dizziness, or drowsiness due to extremely low or high blood sugar, do not drive, use machinery or do any activity that requires alertness or clear vision until you are sure you can do them safely.

In Treatment of Type 2 diabetes mellitus: Victoza® Pre-Filled Pen is an injectable medicine that helps to control high blood glucose (sugar) levels. Lowering blood glucose levels is an essential part of managing diabetes. It helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Proper control of diabetes may also lessen your risk of having a heart attack or stroke.

You will need to learn exactly how, where, and when to inject this insulin for it to be most effective. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.

Warnings and Precautions

Risk of Thyroid C-cell Tumors: If serum calcitonin is measured and found to be elevated, the patient should be further evaluated. Patients with thyroid nodules noted on physical examination or neck imaging should also be further evaluated.

Acute Pancreatitis: Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with liraglutide postmarketing. Observe patients carefully for signs and symptoms of pancreatitis (persistent severe abdominal pain, sometimes radiating to the back with or without vomiting). If pancreatitis is suspected, discontinue Liraglutide promptly and if pancreatitis is confirmed, do not restart.

Acute Gallbladder Disease: Substantial or rapid weight loss can increase the risk of cholelithiasis; however, the incidence of acute gallbladder disease was greater in patients treated with Liraglutide than with placebo even after accounting for the degree of weight loss. If cholelithiasis is suspected, gallbladder studies and appropriate clinical follow-up are indicated.

Hypoglycemia: Adult patients with type 2 diabetes on an insulin secretagogue (eg, a sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia with the use of Liraglutide. The risk may be lowered by a reduction in the dose of insulin secretagogues or insulin. In pediatric patients without type 2 diabetes, hypoglycemia occurred. Inform all patients of the risk of hypoglycemia and educate them on the signs and symptoms.

Heart Rate Increase: Mean increases in resting heart rate of 2 to 3 beats per minute (bpm) were observed in patients treated with Liraglutide. Monitor heart rate at regular intervals and inform patients to report palpitations or feelings of a racing heartbeat while at rest during treatment with Liraglutide. Discontinue Liraglutidein patients who experience a sustained increase in resting heart rate.

Renal Impairment: Acute renal failure and worsening of chronic renal failure, which may sometimes require hemodialysis, have been reported, usually in association with nausea, vomiting, diarrhea, or dehydration. Use caution when initiating or escalating doses of Liraglutide in patients with renal impairment.

Hypersensitivity Reactions: Serious hypersensitivity reactions (eg, anaphylaxis and angioedema) have been reported in patients treated with liraglutide. If a hypersensitivity reaction occurs, patients should stop taking Liraglutide and promptly seek medical advice.

Suicidal Behavior and Ideation: In adult clinical trials, 9 (0.3%) of 3,384 patients treated with Liraglutide and 2 (0.1%) of the 1,941 treated with placebo reported suicidal ideation; one of the Liraglutide treated patients attempted suicide. In a pediatric trial, 1(0.8%) of the 125 Liraglutide treated patients died by suicide. There was insufficient information to establish a causal relationship to Liraglutide. Monitor patients for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior. Discontinue treatment if patients experience suicidal thoughts or behaviors. Avoid Liraglutide in patients with a history of suicidal attempts or active suicidal ideation.

Adverse Reactions: The most common adverse reactions, reported in ≥5% are nausea, diarrhea, constipation, vomiting, injection site reactions, headache, hypoglycemia, dyspepsia, fatigue, dizziness, abdominal pain, increased lipase, upper abdominal pain, pyrexia, and gastroenteritis.

Drug Interactions: Liraglutide causes a delay of gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications. Monitor for potential consequences of delayed absorption of oral medications concomitantly administered with Liraglutide.

Indications and Usage of Victoza®

Victoza® (liraglutide) injection is an injectable medicine used:

  • along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes mellitus;
  • to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes mellitus with known heart disease;

Victoza® is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if Victoza® is safe and effective to lower blood sugar in children under 10 years of age. Buy Victoza pen at okdermo store with worldwide shipping.

Where to buy Victoza cheap, is it possible to buy Victoza online?

You can always purchase Victoza® Pre-Filled Pen Liraglutide 6mg/ml Solution for Injection online via the store. Victoza cost in Canada is the same as other countries.


1ml solution contains 6mg of Liraglutide. One prefilled pen contains 18mg liraglutide, phenol 5.5mg (as preservative), sodium hydroxide, hydrochloric acid, and water for injections q.s.